Maximizing Outsourced Biopharma Production

IN BIOMANUFACTURING, EXPRESSION technology, an optimized process, and the required production capacity are all intertwined. The choice of a prolific expression technology and efforts expended to improve production processes can have a dramatic affect o­n the amount of capacity needed. After the push to build capacity in the past few years, contract biomanufacturers are now focusing o­n improving production efficiencies.

For full article Click Here

Author(s): 
Sandra Fox .
Journal: 
Contract Pharma ,June ,2004.